 |
PDBsum entry 7e2z
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Signaling protein
|
PDB id
|
|
|
|
7e2z
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
219 a.a.
|
 |
|
|
|
|
|
|
|
328 a.a.
|
 |
|
|
|
|
|
|
|
45 a.a.
|
 |
|
|
|
|
|
|
|
278 a.a.
|
 |
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Signaling protein
|
 |
|
Title:
|
 |
Aripiprazole-bound serotonin 1a (5-ht1a) receptor-gi protein complex
|
|
Structure:
|
 |
Guanine nucleotide-binding protein g(i) subunit alpha-1. Chain: a. Synonym: adenylate cyclase-inhibiting g alpha protein. Engineered: yes. Mutation: yes. Guanine nucleotide-binding protein g(i)/g(s)/g(t) subunit beta-1. Chain: b. Synonym: transducin beta chain 1.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: gnai1. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108. Gene: gnb1. Gene: gng2. Escherichia coli, homo sapiens.
|
|
Authors:
|
 |
P.Xu,S.Huang,H.Zhang,C.Mao,X.E.Zhou,D.D.Shen,Y.Jiang,Y.Zhang,H.E.Xu
|
|
Key ref:
|
 |
P.Xu
et al.
(2021).
Structural insights into the lipid and ligand regulation of serotonin receptors.
Nature,
592,
469-473.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
07-Feb-21
|
Release date:
|
14-Apr-21
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P63096
(GNAI1_HUMAN) -
Guanine nucleotide-binding protein G(i) subunit alpha-1 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
354 a.a.
219 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P62873
(GBB1_HUMAN) -
Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
340 a.a.
328 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P59768
(GBG2_HUMAN) -
Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
71 a.a.
45 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Nature
592:469-473
(2021)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural insights into the lipid and ligand regulation of serotonin receptors.
|
|
P.Xu,
S.Huang,
H.Zhang,
C.Mao,
X.E.Zhou,
X.Cheng,
I.A.Simon,
D.D.Shen,
H.Y.Yen,
C.V.Robinson,
K.Harpsøe,
B.Svensson,
J.Guo,
H.Jiang,
D.E.Gloriam,
K.Melcher,
Y.Jiang,
Y.Zhang,
H.E.Xu.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Serotonin, or 5-hydroxytryptamine (5-HT), is an important
neurotransmitter1,2 that activates the largest subtype family of
G-protein-coupled receptors3. Drugs that target 5-HT1A,
5-HT1D, 5-HT1E and other 5-HT receptors are used to treat
numerous disorders4. 5-HT receptors have high levels of basal
activity and are subject to regulation by lipids, but the structural basis for
the lipid regulation and basal activation of these receptors and the pan-agonism
of 5-HT remains unclear. Here we report five structures of 5-HT
receptor-G-protein complexes: 5-HT1A in the apo state, bound to 5-HT
or bound to the antipsychotic drug aripiprazole; 5-HT1D bound to
5-HT; and 5-HT1E in complex with a 5-HT1E- and
5-HT1F-selective agonist, BRL-54443. Notably, the phospholipid
phosphatidylinositol 4-phosphate is present at the G-protein-5-HT1A
interface, and is able to increase 5-HT1A-mediated G-protein
activity. The receptor transmembrane domain is surrounded by cholesterol
molecules-particularly in the case of 5-HT1A, in which cholesterol
molecules are directly involved in shaping the ligand-binding pocket that
determines the specificity for aripiprazol. Within the ligand-binding pocket of
apo-5-HT1A are structured water molecules that mimic 5-HT to activate
the receptor. Together, our results address a long-standing question of how
lipids and water molecules regulate G-protein-coupled receptors, reveal how 5-HT
acts as a pan-agonist, and identify the determinants of drug recognition in 5-HT
receptors.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
| | |